Cargando…

Efficacy and safety of SOX chemotherapy with or without surgery in AFP-producing advanced gastric cancer

The present study investigated the clinical efficacy of S-1 plus oxaliplatin (SOX) regimen, with or without surgery in α-fetoprotein-producing gastric cancer (APGC) with liver metastasis. A total of 24 patients with APGC treated at the Liaocheng People's Hospital between January 2011 and Decemb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Zhu, Hou, Xu, Chen, Juan, Sun, Huidong, Mi, Yuetang, Sui, Yongling, Li, Yuhong, Xie, Jiaping, Qiao, Yingli, Lei, Xiaofeng, Che, Xiaoshuang, Liu, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5494698/ https://www.ncbi.nlm.nih.gov/pubmed/28693208 http://dx.doi.org/10.3892/ol.2017.6240

Ejemplares similares

Efficacy and safety of apatinib for the treatment of AFP-producing gastric cancer
por: Li, Ningning, et al.
Publicado: (2020)

Novel characteristics of alpha-fetoprotein (AFP)-producing gastric cancer
por: Sun, Wenhui, et al.
Publicado: (2017)

Expression of AFP and STAT3 Is Involved in Arsenic Trioxide-Induced Apoptosis and Inhibition of Proliferation in AFP-Producing Gastric Cancer Cells
por: Jia, Yanfei, et al.
Publicado: (2013)

α-Fetoprotein contributes to the malignant biological properties of AFP-producing gastric cancer
por: Mao, Xiang, et al.
Publicado: (2023)

A case of a long-term survival achieved by surgical treatment and chemotherapy for late recurrence of AFP-producing gastric cancer
por: Harada, Manabu, et al.
Publicado: (2019)

AFP-producing hepatoid adenocarcinoma (HAC) of peritoneum and omentum: a case report and literature review
por: Zou, Man, et al.
Publicado: (2019)

Activated Wnt signaling promotes growth and progression of AFP-producing gastric cancer in preclinical models
por: Chen, Dongshao, et al.
Publicado: (2019)

Both the serum AFP test and AFP/GPC3/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinoma
por: Wang, Bingzhi, et al.
Publicado: (2021)

AFP
Publicado: (2009)

Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma
por: Li, Wei, et al.
Publicado: (2020)

AFP-producing hepatoid adenocarcinoma of the stomach: a case report
por: Vlachostergios, Panagiotis J, et al.
Publicado: (2009)

High-dose chemotherapy with autologous peripheral blood stem cell support for recurrent primary AFP-producing intracranial germinoma
por: Ziske, Carsten, et al.
Publicado: (2003)

Status of AFP
por: Erland, Paula Agnieszka
Publicado: (2019)

The AFP Project
por: Staszewski, R.
Publicado: (2011)

Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP
por: Wang, Ya-Kun, et al.
Publicado: (2018)

Analysis of serum alpha-fetoprotein (AFP) and AFP-L3 levels by protein microarray
por: Wu, Min, et al.
Publicado: (2018)

The significance of time interval between perioperative SOX/XELOX chemotherapy and clinical decision model in gastric cancer
por: Chen, Jun-Bing, et al.
Publicado: (2022)

Evaluation of the optimal dosage of S-1 in adjuvant SOX chemotherapy for gastric cancer
por: YANG, LIN, et al.
Publicado: (2015)

AFP-producing acinar cell carcinoma treated by pancreaticoduodenectomy in a patient with a previous radical subtotal gastrectomy by gastric cancer
por: Kim, Chang Young, et al.
Publicado: (2014)

Effective treatment of apatinib for chemotherapy-refractory advanced gastric carcinoma with AFP-secretion and HER2-positivity: A case report
por: Ding, Xinjing, et al.
Publicado: (2021)

DCS and TDAQ for AFP
por: Banas, Elzbieta, et al.
Publicado: (2017)

AFP Project in ATLAS
por: Tasevsky, M
Publicado: (2017)

First AFP results
por: Staszewski, Rafal
Publicado: (2017)

Overview of AFP performance
por: Liu, Jesse Kar Kee
Publicado: (2021)

The ATLAS AFP Spectrometer
por: Newman, Paul Richard
Publicado: (2021)

Overview of AFP Detector
por: Auriol, Adrien
Publicado: (2023)

Individualized therapy based on the combination of mini-PDX and NGS for a patient with metastatic AFP-producing and HER-2 amplified gastric cancer
por: Zhu, Xiaodan, et al.
Publicado: (2022)

Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma
por: Park, Sang Joon, et al.
Publicado: (2017)

Alpha-Fetoprotein (AFP) and AFP-L3 Is Most Useful in Detection of Recurrence of Hepatocellular Carcinoma in Patients after Tumor Ablation and with Low AFP Level
por: Force, Madison, et al.
Publicado: (2022)

Validation of combined AFP, AFP-L3, and PIVKA II for diagnosis and monitoring of hepatocellular carcinoma in Chinese patients
por: Ren, Tianying, et al.
Publicado: (2023)

Status of the AFP Project in ATLAS
por: Tasevsky, Marek
Publicado: (2017)

ATLAS AFP: Status and Prospects
por: Newman, Paul
Publicado: (2018)

The AFP detector control system
por: Oleiro Seabra, Luis Filipe, et al.
Publicado: (2017)

The AFP and CT-PPS projects
por: Royon, C., et al.
Publicado: (2015)

Physics goals and status of AFP
por: Trzebinski, Maciej
Publicado: (2015)

Backgrounds in AFP Detector Estimation
por: Huang, Yicong
Publicado: (2016)

The tracking system of the AFP detector.
por: Dyndal, M
Publicado: (2014)

The AFP Detector Control System
por: Oleiro Seabra, Luis Filipe
Publicado: (2017)

Analysis with AFP and ATLAS Detectors
por: Erland, Paula Agnieszka
Publicado: (2022)

The diagnostic value of PIVKA‐II, AFP, AFP‐L3, CEA, and their combinations in primary and metastatic hepatocellular carcinoma
por: Qi, Famei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_1lb9dd06e63lg9v6sg1413f6kn